Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.

Saved in:
Bibliographic Details
Title: Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.
Authors: de Niet, A.1 (AUTHOR) a.deniet@amc.nl, Takkenberg, R.B.1 (AUTHOR), Benayed, R.2 (AUTHOR), Riley-Gillis, B.2 (AUTHOR), Weegink, C.J.1 (AUTHOR), Zaaijer, H.L.3 (AUTHOR), Koot, M.4 (AUTHOR), Jansen, P.L.M.1 (AUTHOR), Beld, M.G.H.M.5 (AUTHOR), Lopatin, U.6,7 (AUTHOR), Reesink, H.W.1 (AUTHOR)
Source: Scandinavian Journal of Gastroenterology. Apr2012, Vol. 47 Issue 4, p475-481. 7p. 1 Chart, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first